Background The widespread use of short-acting beta-2 agonists (SABA) as an as-needed
treatment for asthma is well-established. However, excessive use of SABA has been linked …

Abstract In the Middle East and Africa (MEA) region, overuse of oral corticosteroids (OCS) for
asthma management, both as burst and maintenance therapy, poses a significant challenge …

Background The extent of short-acting Beta-2-agonist (β 2-agonist)(SABA) use across Asian
countries is not well documented. As part of the SABA use IN Asthma (SABINA) III study, we …

Objective Short-acting β2-agonist (SABA) overuse is associated with poor asthma outcomes;
however, the extent of SABA use in Thailand is largely unknown. As part of the SABA use IN …

The role of as-needed inhaled short-acting β2-agonists (SABAs) in the management of
asthma has become a subject of debate due to differing opinions in the professional …

Abstract Objective Short-acting Beta-adrenergic Receptor Agonists (SABA) carry a risk of
worse asthma outcomes when overused. Beliefs about asthma controller medications are …

Background: Asthma, a chronic disease of airways is associated with recurring episodes of
dyspnea and wheezing that vary in intensity and frequency among individuals. Effective …

Çelebi Sözener ve ark.'nın kliniklerinde takip edilen 405 astım hastasını inceledikleri
2022'de yayınlanan çalışmalarında hastaların yarıya yakın bir kısmının (% 49.6) ağır astımlı …